Apoptosis and production of TNF-α by tumor-associated inflammatory cells in histological grade III breast cancer

Cancer Immunology, Immunotherapy

Volumn 54, Issue 7, 2005, Pages 671-676

  Estevam, Farias Rogério ^a,c   Augusto, Soares Fernando ^b   Rodrigues, Souza Andrezza ^a   Pinheiro, MacHado Raquel Rocha ^a   Monteiro, Aarestrup Fernando ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b Hospital Cancer Registry   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Apoptosis; Breast; Cancer; Ki67; Metastasis; Prognostic; TNF alpha

Indexed keywords

DIGOXIGENIN; GENOMIC DNA; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; ANAMNESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION;

APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21244450705     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-004-0639-0     Document Type: Article

References (25)

1. Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, Grassi MG, Pittalis S, Crispino S, Barni S, Tancini G (1992) Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Reg Hom Agentes 6:103-107
2. Basu A, Mohanty S, Sun B (2001) Differential sensitivity of breast cells to tumor necrosis factor-α: involvement of protein kinase C. Bioch Biophy Res Commu 280:883-891
3. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 were followed for 15 years. Br J Cancer 11:359-377
4. Bower JE, Ganz PA, Aziz N, Fahey JL (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64:604-611
5. Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A (2004) Evidence of immune defects in breast and lung cancer patients. Cancer Immunol Immunother. Epub
6. Chopin V, Slomianny C, Hondermarck H, Le Bourhis X (2004) Synergistic induction of apoptosis in breast cancer cells by co-treatment with butyrate and TNF-alfa, TRAIL, or antibody involves enhancement of death receptor signaling and requires P21(waf1). Exp Cell Res 298(2):569-73
7. Christopher Weldon B, Matthew Burow E, Kevin Rolfe W, John Clayton L, Bernard Jaffe M, Barbara Beckman S (2001) NF-κB-mediated chemoresistance in breast cancer cells. Surgery 130:143-150
8. Cuello M, Ettenberg, Amy Clarrk S, Maccon Keane M, Reuben Posner H, Marion Nau M, Philip Dennis A, Stan Lipkowitz (2001) Down-regulation of the erbB-2 receptor by trastuzumab (Herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res 61:4892-4900
9. De Jong JS, Van Diest PJ, Baak JP (2000) Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J cancer 82:368-373
10. Deregowski Valérie, Delhalle Silvie, Benoit Valérie, Bours Vincent, Merville Marie-Paule (2002) Identification of cytokine-induced nuclear factor-kappa B target genes in ovarian and breast cancer cells. Bioch Pharm 64:873-881
11. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer I. The value of histological grades in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19:403-410
12. Fujiki H, Suganuma M, Okabe S, Kurursu M, Imai K, Nakachi K (2002) Involvement of TNF-alpha changes in human cancer development, prevention and palliative care. Mech Ageing Dev 123:1655-1663
13. Gandhi A, Holland PA, Knox WF, Poten CS, Bundred NJ (1998) Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast. Br J Cancer 78:788-794
14. González-Cámpora R, Ruiz MRG, Ramirez FV, Martin JJR, Santos JMF, Martos MMR, Pascual AG (2000) Apoptosis in breast cancer. Pathol Res Pract 196:167-174
15. Hagemann T, Robison SC, Schulz M, Trumper L, Balkwill FR, Blinder C (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-{alfa}- dependent up-regulation of matrix metalloproteases. Carcinogenesis 25(8):1543-1549
16. Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y, Vignaud JM (2002) Tumor infiltrant limphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab clin Med 140:320-328
17. Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S (2003) Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor or TNF-related apoptosis-inducing ligand in human cancer cell lines. Cancer Res 63:621-626
18. Korobko EV, Saschenco LP, Prockhorchouk EB, Korobko IV, Gnuchev NV, Kiselev SL (1999) Resistance to tumor necrosis factor-induced apoptosis in vitro correlates with high metastatic capacity of cells in vivo. Immunol Lett 67:71-76
19. Nishimura R, Nagao K, Myayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Higuchi A (1999) Apoptosis in breast cancer and its relationship to clinicopathological characteristics and prognosis. J surg Oncol 71:226-234
20. Park KS, Mok JW, Ko HE, Tokunaga K, Lee MH (2002) Polymorphism of tumor necrosis factors A and B in breast cancer. Eur J Immunogenet 29:7-10
21. RamaKrishnan R, Werbeck J, Khurana KK, Khan AS (2003) Expression of interleukin-6 and tumor necrosis alpha and histopathologic findings in painful and nonpainful breast tissue. Breast J 9:91-97
22. Sabel MS, Skitzki J, Stoolman L, Egilmez NK, Mathiowitz E, Bailey N, Chang WJ, Chang AE (2004) Intratumoral IL-12 and TNF-alfa-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity. Ann Surg Oncol 11(2):147-156
23. See D, Mason S, Roshan R (2002) Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest 31:137-153
24. Shen WH, Zhou JH, Broussard SR, Freund GG, Dantzer R, Kelley KW (2002) Pro-inflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res 62:4746-4756
25. Simiantonaki N, Jayasinghe C, Kirkpatrick CJ (2002) Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro. Exp Mol Pathol 73:46-53